In vivo and in vitro diclofenac sodium evaluation after rectal application of soft gelatine capsules enabling application induced transformation (AIT) into a semisolid system of liquid crystals (SSLC) for controlled release

被引:22
作者
Schneeweis, A [1 ]
Müller-Goymann, CC [1 ]
机构
[1] Tech Univ Braunschweig, Inst Pharmazeut Technol, D-38106 Braunschweig, Germany
关键词
diclofenac sodium; lecithin; liquid crystals; reverse micellar solution; controlled release; rectal application;
D O I
10.1023/A:1012127829032
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose, Reverse micellar solutions of diclofenac sodium were encapsulated in soft gelatine capsules. On contact with aqueous media they exhibited an application induced transformation (AIT) into a semisolid system of liquid crystals (SSLC) which slows down drug release. The aim of the present paper was to study in vitro and in vivo drug release from these systems after rectal application. Methods, In vitro, drug release was determined in a self-constructed dissolution apparatus to simulate rectal application. For in vitro bioavailability studies rabbits were used as animal models. In vitro release and in vivo bioavailability of the capsules was compared to Voltaren(R) suppositories. Results. The release profiles of the in vitro experiments show zero-order kinetics. The in vivo bioavailability studies show bioequivalence in terms of AUC for both formulations (capsules and Voltaren(R) suppositories). The mean residence time (parameter of sustained release) of the capsules is three time longer in comparison to Voltaren(R) suppositories. Conclusions. Rectal administration of capsules provides an appropiate route for controlled release via AIT-SSLC which could be clearly verified in rabbits.
引用
收藏
页码:1726 / 1729
页数:4
相关论文
共 14 条
[1]   RECTAL MUCOSA DAMAGE IN RABBITS AFTER SUBCHRONICAL APPLICATION OF SUPPOSITORY BASES [J].
DEMUYNCK, C ;
CUVELIER, C ;
VANSTEENKISTE, D ;
BONNARENS, L ;
REMON, JP .
PHARMACEUTICAL RESEARCH, 1991, 8 (07) :945-950
[2]  
GUITARD P, 1991, PHARM TECHNOLOGIE, P383
[3]   FITTING OF DIFFUSION-COEFFICIENTS IN A 3-COMPARTMENT SUSTAINED-RELEASE DRUG FORMULATION USING A GENETIC ALGORITHM [J].
HIRSCH, R ;
MULLERGOYMANN, CC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 120 (02) :229-234
[4]  
HIRSCH R, 1996, THESIS TU BRAUSNCHWE
[5]  
MIGNAT C, 1991, THESIS TU BRAUNSCHWE
[6]  
MUELLER BW, 1986, SUPPOSITORIEN, P45
[7]   SUSTAINED-RELEASE FROM REVERSE MICELLAR SOLUTIONS BY PHASE-TRANSFORMATIONS INTO LAMELLAR LIQUID-CRYSTALS [J].
MUELLERGOYMANN, CC ;
HAMANN, HJ .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (02) :165-174
[8]   A LOCALLY MODIFIED 2ND-ORDER UPWIND SCHEME FOR CONVECTION TERMS DISCRETIZATION [J].
PAPADAKIS, G ;
BERGELES, G .
INTERNATIONAL JOURNAL OF NUMERICAL METHODS FOR HEAT & FLUID FLOW, 1995, 5 (01) :49-62
[9]  
PAPANTONIOU I, 1995, PHARM PHARM LETT, V5, P28
[10]  
PAPANTONIOU I, 1995, THESIS TU BRAUNSCHWE